1. |
Simard EP, Ward EM, Siegel R, et al. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin, 2012, 62(2): 118-128.
|
2. |
Germano D, Daniele B. Systemic therapy of hepatocellular carcinoma: current status and future perspectives. World J Gastroenterol, 2014, 20(12): 3087-3099.
|
3. |
Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg, 2005, 189(1): 120-125.
|
4. |
Willekens I, Hoorens A, Geers C, et al. Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia. World J Gastroenterol, 2009, 15(31): 3940-3943.
|
5. |
Yu XH, Xu LB, Zeng H, et al. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int, 2011, 10(6): 620-625.
|
6. |
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 1997, 3(7): 730-737.
|
7. |
Babaie Y, Herwig R, Greber B, et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells, 2007, 25(2): 500-510.
|
8. |
Branda M, Wands JR. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology, 2006, 43(5): 891-902.
|
9. |
Ishizaki Y, Ikeda S, Fujimori M, et al. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol, 2004, 24(5): 1077-1083.
|
10. |
Zhang F, Chen XP, Zhang W, et al. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology, 2008, 52(2): 224-232.
|
11. |
Kühl M. Non-canonical Wnt signaling in Xenopus: regulation of axis formation and gastrulation. Semin Cell Dev Biol, 2002, 13(3): 243-249.
|
12. |
Sell S, Leffert HL. Liver cancer stem cells. J Clin Oncol, 2008, 26(17): 2800-2805.
|
13. |
Mishra L, Banker T, Murray J, et al. Liver stem cells and hepatocellular carcinoma. Hepatology, 2009, 49(1): 318-329.
|
14. |
Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology, 2006, 44(1): 240-251.
|
15. |
Durnez A, Verslype C, Nevens F, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology, 2006, 49(2): 138-151.
|
16. |
Münz M, Kieu C, Mack B, et al. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene, 2004, 23(34): 5748-5758.
|
17. |
Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell, 2012, 21(3): 283-296.
|
18. |
Yamashita T, Ji J, Budhu A, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology, 2009, 136(3): 1012-1024.
|
19. |
Lázaro CA, Chang M, Tang W, et al. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol, 2007, 170(2): 478-489.
|
20. |
Arzumanyan A, Friedman T, Ng IO, et al. Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res, 2011, 71(10): 3701-3708.
|
21. |
Ali N, Allam H, May R, et al. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. J Virol, 2011, 85(23): 12292-12303.
|
22. |
Visvader JE. Cells of origin in cancer. Nature, 2011, 469(7330): 314-322.
|
23. |
Chaffer CL, Brueckmann I, Scheel C, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A, 2011, 108(19): 7950-7955.
|
24. |
Chen Y, Wong PP, Sjeklocha L, et al. Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture. Hepatology, 2012, 55(2): 563-574.
|
25. |
Yang ZF, Ho DW, Ng MN, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell, 2008, 13(2): 153-166.
|
26. |
Sell S. Cellular origin of hepatocellular carcinomas. Semin Cell Dev Biol, 2002, 13(6): 419-424.
|
27. |
Zender L, Spector MS, Xue W, et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell, 2006, 125(7): 1253-1267.
|